Left ventricular aneurysm (LVA) is a common sequela to myocardial infarction, occurring in 10% to 30% of patients surviving an acute myocardial infarction.'" Many studies have shown that patients with LVA have a higher mortality rate than those with normal left ventricular function4v5 and have suggested that these patients are particularly susceptible to severe ventricular arrhythmias,'j-lo thromboembolic phenomena,', 7, lo and congestive heart failure.13 5~7, g-11
Surgical resection of LVA has been commonly performed in an effort to treat these problems, and many studies suggest improvement in survival rate and functional status after aneurysmectomy or aneurysmorrhaphy.sp lo, 12e20 However, these procedures are associated with a high operative mortality rate, and there have been no controlled, randomized, prospective studies on the efficacy of these proce-dures. Furthermore, it is not clear whether the morbidity and mortality associated with LVA are the result of the segmental dysfunction itself or can be attributed to the severe overall left ventricular dysfunction with which it is often associated. The purpose of this study was to determine whether or not LVA is an independent risk factor for cardiac morbidity and mortality in patients with coronary artery disease.
METHODS

Patient
selection.
All cardiac catheterizations (n = 895) performed at the University of Michigan Hospital between January 1, 1978, and December 31, 1979, were reviewed. LVA was defined as any dyskinetic (outward systolic motion) segment of the left ventricle. All patients with such an abnormality on ventriculography were selected for study (LVA group) . The control group consisted of all patients with akinetic segment(s) of the left ventricle (no systolic motion), ejection fraction of less than 60%, and no areas of dyskinesis.
Excluded from these patients were those with greater than a 15 mm Hg gradient across the aortic valve (two patients in the control group and one in the LVA group), those with mitral valve areas less than 1.0 cm2 (two patients in the control group), and those with greater than 23 
NS NS
Abbreviations SD = standard deviation; NS = not significant; MI = myocardial infarction; CHF = congestive heart failure; VT = ventricular tachycardia; PM1 = point of maximal impulse; S, = third heart sound, Sl = fourth heart sound; JVD = jugular venous distention. *Data are expressed as percentage of group with each characteristic unless otherwise indicated.
l+ mitral or aortic insufficiency (one patient in the LVA group). Also excluded were those with ventricular septal defect (one in the LVA group), those without at least a 70% stenosis of at least one major coronary artery (one in the control group), those who died during cardiac catheterization (two in the LVA group), those for whom medical records were unavailable (two in each group), those in whom no coronary angiography was performed (one in the control group), and those who bad undergone previous cardiac valve replacement (one in each group). There are 23 patients with akinesis who were excluded because of ejection fractions > 60%. Three patients had undergone previous coronary artery bypass surgery at the time of entry into the study (two in the LVA group and one in the control group). After these patients were excluded, the LVA group contained 39 patients and the control group, 28 patients. In the LVA group, four patients had l+ mitral insufficiency, one had a 10 mm Hg aortic valve gradient, and one had l+ aortic insufficiency. In the control group, one patient had a 10 mm Hg aortic valve gradient, one had l+ mitral insufficiency, and one had l+ aortic insufficien-CY. catheterization report data were ambiguous or inconsistent. All of the ventriculograms were technically adequate and had sufficient opacification for determination of regional and global wall motion. Ejection fractions were measured on sinus beats only. Postectopic beats were excluded for analysis unless these were the only sinus beats available. A vessel was considered diseased if a stenosis of at least 70% was present.
Clinical data. The medical record of each patient was reviewed. History and physical examination obtained at the time of cardiac catheterization were used to determine the presence of previous myocardial infarction, the presence and severity of angina and congestive heart failure, the presence of ventricular arrhythmias and thromboembolic phenomena, the presence of cardiac risk factors, and evidence of abnormal cardiac physical findings. Each patient had a standard 12-lead ECG and a chest x-ray prior to catheterization.
Forty patients underwent multiple-gated acquisition radionuclide ventriculograms using in vivo labeled red blood cells and 16 frames/cardiac cycle gating. Several patients had other diagnostic studies including exercise tests, ambulatory ECG monitoring, radionuclide ventriculography, thallium perfusion studies, and invasive electrophysiologic studies, all of which were also recorded.
The follow-up period was defined as commencing with the day following cardiac catheterization and ending with the most recent available date of follow-up or death. Data pertaining to this period were obtained from the medical records, by contact with the patients' physicians, or by contact with the patients themselves or their surviving family. Information specifically sought included the performance of cardiac surgery, presence and severity of angina pectoris, congestive heart failure and ventricular arrhythmias, the presence of thromboembolic phenome-na, and death. If death occurred, information concerning the cause of death was obtained. Statistical comparisons between the akinetic and dyskinetic groups were made by means of Student's unpaired t test for continuous variables and chi square with continuity correction for discrete variables.
RESULTS
Clinical
data at the time of catheterization.
The demographic, historic, and physical examination data obtained at the time of catheterization in each group are summarized in Table I . There were no statistically significant differences between the two groups with respect to age, sex, and cardiac morbidity. The prevalence of cardiac risk factors was similar in both groups. Third and fourth heart sounds and peripheral edema were more common in the LVA group than in the control group.
Noninvasive data at the time of catheterization. ECG and chest x-ray findings are summarized in Table II . There was a trend to more old anterior myocardial infarctions in the aneurysm group, which approached statistical significance. The presence of ST segment elevation was very specific for LVA but was only present in a minority of patients with this lesion. The prevalence of cardiomegaly on chest x-ray was significantly higher in the LVA group.
Radionuclide ventriculography was performed in 27 patients in the LVA group and in 13 in the control group. Dyskinetic segments were seen in 48% of the LVA patients studied and in 8% of the control patients studied. The single patient in the control group with dyskinesis shown by radionuclide study was alive and free of cardiovascular events 42 months after catheterization and should not alter the conclusions of this study even if the patient might be considered misclassified. Four of the six patients in the LVA group who underwent twodimensional echocardiography were found to have evidence of segmental dyskinesis, whereas only one out of three control patients had this echocardiographic finding.
Catheterization data. The finding of cardiac catheterization are outlined in Table III . The two groups were well matched for mean ejection fraction (43% in the LVA group, 45 % in the control group) and the extent and distribution of coronary artery disease. There was a significantly higher mean left ventricular end-diastolic pressure in the LVA group and a lower mean cardiac index which approached statistical significance. The distribution of dyskinetic segments in the LVA group was markedly different from the distribution of akinetic segments in the control group, with the apex more frequently involved in the former group and inferior, posterobasal, and lateral wall involvement more frequent in the latter group. Follow-up data. The mean duration of follow-up was 33 f 19 months in the LVA group (range 1 to 55 months) and 31 -t 13 months in the control group (range 1 to 47 months) (p = 0.67). Cardiac surgery was performed during the follow-up period in 17 (44%) patients in the LVA group and in 12 (43% ) patients in the control group. In all except one patient (who had an aneurysmectomy only), all procedures consisted of coronary artery bypass grafting with an average of 1.8 bypasses/patient in the LVA group and 2.5 bypasses/patient in the control group. Twelve LVA patients underwent concomitant (or isolated in one patient) aneurysmectomy or aneurysmorrhaphy.
No valve replacements were performed, reflecting the exclusion of patients with significant valvular disease. The operative mortality rate, defined as death within 24 hours of surgery, was 4 out of 17 LVA patients (23%) and 1 out of 12 control patients (8.3%). The outcome of medical and surgical therapy in both groups is outlined in Fig. 1 .
In an attempt to ascertain the effect of aneurys- mectomy or aneurysmorrhaphy on symptoms of congestive heart failure, Fig. 2 compares the initial and follow-up functional status in LVA patients who underwent this procedure with those aneurysm patients who did not. No clear benefit from this procedure could be demonstrated.
The overall mortality rate in the resected group was 58% compared to 30% in the unresected group.
Clinical status at the most recent time of followup or at the time just prior to death is outlined in Table IV . The frequency of clinically evident congestive heart failure, angina, ventricular tachycardia, recurrent myocardial infarction, and cerebrovascular events as not significantly different between the two groups. In neither group was an event identified that was clearly embolic in origin. Many of the patients who experienced a cerebrovsscular event had known cerebrovascular disease. None of the patients was on chronic anticoagulation therapy during the study.
When angina and congestive heart failure were graded by New York Heart Association criteria and the two groups compared according to the severity of these symptoms, there was no statistically significant difference between these two groups (Fig. 3) .
The mortality rate was 38% in the LVA group and 32% in the control group, a difference which is not statistically significant (p = 0.59). Among patients in the LVA group, the causes of death were cardiac in 11 (one sudden death, four congestive heart failure, two ventricular arrhythmia, and four recurrent myocardial infarction), noncardiac in one (cancer), and undetermined in three. Among control paitents, the causes of death were cardiac in five (one congestive heart failure, two ventricular arrhythmia, and two recurrent myocardial infarction), noncardiac in three (chronic obstructive pul- monary disease, cancer, and cirrhosis), and undetermined in one patient. When death, myocardial infarction, and cerebrovascular accidents were grouped together as endpoint events, there was still no significant difference between the two groups (mean incidences: 20.3% in the LVA group and 16.7% in the control group).
DISCUSSION
That global left ventricular dysfunction is a major prognostic indicator in patients with ischemic heart disease has been well established. Whether or not segmental left ventricular function has the same significance, independent of ejection fraction, has not been determined. LVA, the most advanced form of segmental dysfunction, is often associated with global dysfunction and, therefore, may not be specifically responsible for the increased morbidity and mortality often attributed to it.
EWier studies. Only two other studies have examined the prognostic significance of LVA independent of overall left ventricular function.4s21 Faxon et al.,4 by means of data obtained from the Coronary Artery Surgery Study, found that the higher $-year mortality rate in patients with LVA (defined as dyskinesis or akinesis), as compared to patients without LVA, was no longer demonstrable when the LVA patients were compared to patients without LVA but with similar degrees of residual or total left ventricular dysfunction. or akinesis associated with a diastolic contour abnormality in the setting of acute anterior transmural myocardial infarction. They found a 6.7-fold greater l-year mortality rate (61% vs 9%) in those patients whose infarctions were associated with acute LVA formation as compared to those patients whose infarctions
were not. The Meizlish study differs from the Faxon study, as well as the present study, because it examines patients with acute (not remote) infarction, it uses nuclear (not angiographic) techniques, and it uses a different definition of LVA. The present study adds to these earlier studies by examining the cardiac morbidity as well as the mortality rate associated with LVA by assessing the effectiveness of surgical resection in a controlled (albeit nonrandomized) fashion and by restricting the control group to those with discrete segmental abnormalities.
The central issue of this study is of significant interest since the traditional therapy of LVA, that is, aneurysmectomy, is of unproved efficacy and is associated with a high operative mortality rate (3.3 % to 50% )."* 14, 15, ~3, 22-24 Furthermore, the results of many studies on the effectiveness of surgical resection on cardiac morbidity and mortality are highly variable, uncontrolled, and usually complicated by concomitant revasularization.g* 12mzo
The definition of LVA in the literature has been quite variable, with debate focusing on the degree of the necessary wall motion abnormality,4T 5, 16, 21 the diastolic contour,4* la* 2L histologic composition,'* 7 wall thickness, and discreteness of its margins.4 Much of this disagreement is related to the inherent differences between clinical, surgical, and pathologic studies. Clearly, the definition of .the term "left ventricular aneurysm" is not as important as the definition of specific abnormalities of left ventricular function which identify a subset of patients with distinctive clinical and hemodynamic characteristics.
For the purpose of this study, LVA is used to Lower, Severity of congestive heart failure (New York Heart Association classification). None of the observed differences between the two groups is statistically significant.
describe a segment of the left ventricle which is dyskinetic at rest during ventriculography. The control group contained patients with 'one or more segments revealing akinesis (but no dyskinesis) and an ejection fraction less than 60%. A population of patients with akinesis was chosen as a control group for two reasons. A regional wall motion abnormality was needed in this group in order to provide a population with a reduced mean ejection fraction comparable to that of the LVA group while excluding those patients with primary (and more likely global) myocardial disease 'who might have a different natural history than those with ischemic (and more likely segmental) myocardial disease. Akinesis was chosen as the necessary abnormality in the control group in order to provide a population of patients for comparison with as severe a regional abnormality as possible short of LVA. If patients in the control group with high ejection fractions were not excluded, the less severe regional abnormality present in this group would have resulted in a higher mean ejection fraction than in the LVA group. Since ejection fraction is known to have major prognostic significance, failure to have comparable mean ejection fractions in the two groups would have made conclusions about the prognostic significance of LVA impossible. Whether the lower mean ejection fraction in the LVA group (prior to the previously mentioned exclusions) can be attributed solely to the systolic expansion of the aneurysm or is, in part, the result of a greater degree of overall left ventricular dysfunction cannot be ascertained from this study.
Morbidity
of left ventricular aneurysm.
The major clinical problems most frequently attributed to LVA are congestive heart failure, malignant ventricular arrhythmias, thromboembolic phenomena, and an increased mortality rate. This study provides evidence that patients with LVA are at no more risk for these problems than are patients with similar ejection fractions and coronary artery disease but who are free of LVA.
The reported incidence of congestive heart failure in patients with LVA ranges from 21% to 86 % .I, 7, g-1* In this study, 32% of patients with LVA had congestive heart failure, which was not statistically different from the incidence of 29% in the control group. This finding suggests that the experimentalz4 and theoretic25 hemodynamic burden imposed by an expansile segment of the left ventricle may be clinically important only insofar as it reduces the overall ejection fraction. Thromboembolic phenomena have frequently been reported to be associated with LVA, the incidences ranging from 0 % to 20% in clinical studies5s lo, I1 and 9% to 52% in pathologic studies.ls' The frequent discrepancy between clinical and pathologic studies may reflect either the high incidence of clinically occult emboli, the failure to recognize a vascular event as embolic in nature, or the inherent differences in patient populations. None of the patients in this study was anticoagulated, and none had a clearly embolic event. There are several cerebrovascular events in both groups, but all of these were clinically or angiographically believed to be the result of intrinsic cerebrovascular disease.
With the widespread emergence of endocardial mapping and other invasive electrophysiologic studies,17*26 new antiarrhythmic agents, and surgical treatment of ventricular arrhythmias,gs 12* 13, 26 there is much interest in the identification of patients at high risk for malignant arrhythmias.8r l7 Malignant arrhythmias have been reported to occur in 14% to 40% of patients with LVA.7-'o Whether this incidence is a reflection of a peculiar property of LVA or simply a manifestation of the severe underlying heart disease has not yet been addressed. The results of this study support the latter view in that the incidence of ventricular tachycardia and fibrillation was not significantly different between the two groups. It must be acknowledged, however, that ambulatory monitoring was not routinely performed and that there was a trend (which fails to reach statistical significance) toward more ventricular tachycardia in the LVA group. This observation is in agreement with another recent study addressing this issue.8
Death from LVA. The mortality rates were high in each group but not significantly different from each other. In comparison with the study by Faxon et a1.,4 in which the mean ejection fraction among patients with LVA was similar to that of this study, the present mortality rate was somewhat higher (38% over 33 months compared to 21% over 36 months). This may reflect differences in the timing of the index catheterization, the slightly higher mean age and higher incience of congestive heart failure in this study, or a reflection of the difference in definition of LVA. Nevertheless, this study agrees with the conclusion of the Faxon study that LVA does not increase the mortality rate independent of overall left ventricular function. These conclusions are in sharp contrast to those of the study by Meizlish et a1.2' It may be that LVA is associated with an increased mortality rate during the first year of its formation but not thereafter. Alternatively, the differences may reflect the use of nuclear techniques to make the diagnosis of LVA which, in the present study, is very specific but not very sensitive when compared to angiographic techniques. The mortality figures from other studies of LVA are highly variable and uncontrolled, with most of the earlier studies showing much higher mortality rates, such as 73 % in 3 years,', 28 73 % at 5 years,' or an average postmyocardial infarction survival rate of only 4.8 yearsZg Another interesting finding was that the 12 patients who underwent either aneurysmectomy or aneurysmorrhaphy did not demonstrate any significant functional advantage over those 26 patients in whom these procedures were not performed and, in fact, had volume 111 Number 1 a much higher mortality rate. Although these numbers are small, the data retrospective, and the patients nonrandomized, this is the first published series of surgical therapy in which a control group of unresected patients is available for comparison.
Clinical characteristics of LVA. It is interesting that clinical different&ion between the two groups was not reliably possible, even with the use of noninvasive diagnostic studies. Two-dimensional echocardiography, electrocardiography, and radionuclide ventriculography were reasonably specific (67 % , 85 % , and 92 % , respectively) but had surprisingly low sensitivities (67 % ,41% , and 48%) respectively). This contrasts with the results of other studies on the utility of these techniques in the diagnosis of LVA 30.33
The higher mean left ventricular end-diastolic pressure in the WA group was statistically significant and seems to indicate decreased diastolic compliance of the aneurysmal left ventricle, since the mean ejection fraction and mean cardiac index were not significantly different between the two groups. This property is in obvious contrast to the higher systolic compliance of a dyskinetic segment when compared to an akinetic one. This finding is in agreement with an earlier study by Klein et alz6
There was an interesting, although not statistically significant, trend toward less severe coronary artery disease, less angina, and fewer bypassed vessels in the patients with LVA. Another interesting observation is that, despite the similar distribution of coronary artery disease (including the left anterior descending artery) in the two groups, there was a striking predilection for aneurysms to involve the apical segment of the left ventricle. Eighty-five percent of the aneurysms involved this segment compared to only 43% of the akinetic segments in the control group. This predilection is in agreement with many other studies.'~4~g**6, *' Whether or not these observed differences in hemodynamics, coronary disease, and distribution of segmental dysfunction between these two groups are identifying distinct subsets of patients remains to be determined.
In summary, this study suggests that LVA, in patients with coronary artery disease, is not a significant risk factor for cardiac morbidity or mortality when compared with patients without aneurysms but with similar degrees of left ventricular dysfunction as measured by ejection fraction. 
